Xiang, Tingbing – Trademark Portfolio
Entity Type: 01
Xiang, Tingbing holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include JSPUK, BIMTVO, NJUBKI, OVITHRI, and ZOLYLUM. The owner is based in Xiangxi, Hunan.
No. 21, Group 9, Qianwei Village
Zhaoshi Town, Longshan County
Xiangxi, Hunan 416816 , CN
Showing of trademarks Trademarks
Trademark Classifications
Xiang, Tingbing's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Xiang, Tingbing have?
Xiang, Tingbing has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.
What trademark classes does Xiang, Tingbing file in?
Xiang, Tingbing files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Xiang, Tingbing's most well-known trademarks?
Xiang, Tingbing's registered trademark portfolio includes well-known marks such as JSPUK, BIMTVO, NJUBKI, OVITHRI, and ZOLYLUM. These are among 6 currently registered trademarks in the portfolio.
What is Xiang, Tingbing's trademark registration success rate?
Xiang, Tingbing has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.